What are the financial and economic costs associated with the implementation of depression screening tools, specifically PHQ-2 and PHQ-9, for patients with substance use disorder? This includes the cost to society, cost to implement, incremental cost, opportunity cost, and other economic costs/benefits associated with an anxiety screening project. Additionally, What are the economic impacts of depression screening for substance use disorder patients?